Study design considerations for the Standardized Treatment Of Pulmonary exacerbations 2 (STOP2): a trial to compare intravenous antibiotic treatment durations in CF

BACKGROUND: Pulmonary exacerbations (PEx) in cystic fibrosis (CF) are common and contribute to morbidity and mortality. Duration of IV antibiotic therapy to treat PEx varies widely in the US, and there are few data to guide treatment decisions. METHODS: We combined a survey of CF stakeholders with r...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Contemp Clin Trials
Asıl Yazarlar: Heltshe, Sonya L., West, Natalie E., VanDevanter, Donald R., Sanders, D. B., Beckett, Valeria V., Flume, Patrick A., Goss, Christopher H.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5742044/
https://ncbi.nlm.nih.gov/pubmed/29170074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2017.11.012
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller